Related Experiment Videos
Chronic administration of amiodarone and thyroid function: a follow-up study.
American Heart Journal
|November 1, 1984
Summary
Chronic amiodarone use significantly impacts thyroid function, leading to a 16% incidence of thyroid dysfunction and increased hyperresponsiveness to thyrotropin-releasing hormone (TRH) stimulation.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Amiodarone is an effective antiarrhythmic drug.
- Its use is associated with various adverse effects, including thyroid dysfunction.
Purpose of the Study:
- To evaluate the effects of chronic amiodarone treatment on thyroid function.
- To assess the prevalence of thyroid dysfunction and thyrotropin-releasing hormone (TRH) stimulation abnormalities in patients on long-term amiodarone therapy.
Main Methods:
- Prospective study of 43 patients on chronic amiodarone treatment (mean duration >9 months).
- Thyroid function tests (T3, T4, rT3, TSH) and TRH stimulation tests were performed at baseline and 12-18 months later.
Main Results:
- At baseline, 5 patients (11.6%) had overt thyroid dysfunction (hypothyroidism or hyperthyroidism).
- Mean T4 and rT3 levels were elevated, while T3 levels were decreased in the remaining patients.
- Thirteen patients (30%) showed hyperresponsiveness to TRH.
- Over 12-18 months, 2 new cases of hypothyroidism developed, and T3 levels decreased further.
- TSH levels and TRH-stimulated TSH increased significantly, with 5 new hyperresponders to TRH.
Conclusions:
- Chronic amiodarone administration is associated with a progressive increase in thyroid dysfunction.
- A high prevalence of hyperresponsiveness to TRH stimulation is observed.
- Long-term amiodarone therapy carries a significant risk of developing thyroid dysfunction.